Transthyretin Mediated Amyloidosis (ATTR) Completed Phase 1 Trials for Patisiran (DB14582)

Also known as: Transthyretin-Mediated Amyloidosis / Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) / Amyloidogenic Transthyretin (ATTR) Amyloidosis / Transthyretin (TTR)-Mediated Amyloidosis / Amyloidosis in Transthyretin (TTR) / Amyloid Transthyretin (ATTR) Amyloidosis / ATTR Amyloidosis

IndicationStatusPhase
DBCOND0047425 (Transthyretin Mediated Amyloidosis (ATTR))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02053454A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy VolunteersTreatment